Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals? ; day:22 ; month:7 ; year:2020 ; pages:1-20
Clinical pharmacokinetics ; (22.7.2020), 1-20
- Urheber
-
Bukkems, Vera E.
Colbers, Angela
Marzolini, Catia
Molto, Jose
Burger, David M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-020-00914-x
- URN
-
urn:nbn:de:101:1-2020091818462129109953
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bukkems, Vera E.
- Colbers, Angela
- Marzolini, Catia
- Molto, Jose
- Burger, David M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug–Drug Interactions with Direct Oral Anticoagulants
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
Clinically relevant drug–drug interactions among elderly people with dementia
Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir
A Review of Daclatasvir Drug–Drug Interactions
Extracting drug-drug interactions from biomedical texts
Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)
DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Lurasidone drug-drug interaction studies: a comprehensive review
Drug–Drug Interactions with Direct Oral Anticoagulants
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
Clinically relevant drug–drug interactions among elderly people with dementia
Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir
A Review of Daclatasvir Drug–Drug Interactions
Extracting drug-drug interactions from biomedical texts
Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)
DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Lurasidone drug-drug interaction studies: a comprehensive review
Drug–Drug Interactions with Direct Oral Anticoagulants
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
Clinically relevant drug–drug interactions among elderly people with dementia
Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir
A Review of Daclatasvir Drug–Drug Interactions
Extracting drug-drug interactions from biomedical texts
Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)
DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)